BioCentury
ARTICLE | Clinical News

The Liposome Company Inc. preclinical data

September 26, 1994 7:00 AM UTC

A separate form of PG E1, TLC C-54, is being developed for rheumatoid arthritis and lupus, LIPO said. ...